<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhu YH</submitter><funding>National Research Foundation of Korea</funding><pagination>225-233</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6458232</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>59(2)</volume><pubmed_abstract>A novel alcohol dehydrogenase from &lt;i>Bartonella apis&lt;/i> (BaADH) was heterologous expressed in &lt;i>Escherichia coli&lt;/i>. Its biochemical properties were investigated and used to catalyze the synthesis of ethyl (S)-4-chloro-3-hydroxybutanoate ((S)-CHBE), which is a chiral intermediate of the cholesterol-lowering drug atorvastatin. The purified recombinant BaADH displayed 182.4 U/mg of the specific activity using ethyl 4-chloroacetoacetate as substrate under the conditions of 50 °C in pH 7.0 Tris-HCl buffer. It was stable in storage buffers of pH 7 to 9 and retains up to 96.7% of the initial activity after 24 h. The &lt;i>K&lt;/i> &lt;sub>m&lt;/sub> and &lt;i>V&lt;/i> &lt;sub>max&lt;/sub> values of BaADH were 0.11 mM and 190.4 μmol min&lt;sup>-1&lt;/sup> mg&lt;sup>-1&lt;/sup>, respectively. Synthesis of (S)-CHBE catalyzed by BaADH was performed with a cofactor regeneration system using a glucose dehydrogenase, and a conversion of 94.9% can be achieved after 1 h reaction. Homology modeling and substrate docking revealed that a typical catalytic triad is in contact with local water molecules to form a catalytic system. The results indicated this ADH could contribute to the further enzymatic synthesis of (S)-CHBE.</pubmed_abstract><journal>Indian journal of microbiology</journal><pubmed_title>Cloning, Expression and Characterization of a Highly Active Alcohol Dehydrogenase for Production of Ethyl (S)-4-Chloro-3-Hydroxybutyrate.</pubmed_title><pmcid>PMC6458232</pmcid><funding_grant_id>NRF-2018H1D3A2001746</funding_grant_id><pubmed_authors>Liu CY</pubmed_authors><pubmed_authors>Cai S</pubmed_authors><pubmed_authors>Zhang YW</pubmed_authors><pubmed_authors>Lee JK</pubmed_authors><pubmed_authors>Kim IW</pubmed_authors><pubmed_authors>Zhu YH</pubmed_authors><pubmed_authors>Kalia VC</pubmed_authors><pubmed_authors>Guo LB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cloning, Expression and Characterization of a Highly Active Alcohol Dehydrogenase for Production of Ethyl (S)-4-Chloro-3-Hydroxybutyrate.</name><description>A novel alcohol dehydrogenase from &lt;i>Bartonella apis&lt;/i> (BaADH) was heterologous expressed in &lt;i>Escherichia coli&lt;/i>. Its biochemical properties were investigated and used to catalyze the synthesis of ethyl (S)-4-chloro-3-hydroxybutanoate ((S)-CHBE), which is a chiral intermediate of the cholesterol-lowering drug atorvastatin. The purified recombinant BaADH displayed 182.4 U/mg of the specific activity using ethyl 4-chloroacetoacetate as substrate under the conditions of 50 °C in pH 7.0 Tris-HCl buffer. It was stable in storage buffers of pH 7 to 9 and retains up to 96.7% of the initial activity after 24 h. The &lt;i>K&lt;/i> &lt;sub>m&lt;/sub> and &lt;i>V&lt;/i> &lt;sub>max&lt;/sub> values of BaADH were 0.11 mM and 190.4 μmol min&lt;sup>-1&lt;/sup> mg&lt;sup>-1&lt;/sup>, respectively. Synthesis of (S)-CHBE catalyzed by BaADH was performed with a cofactor regeneration system using a glucose dehydrogenase, and a conversion of 94.9% can be achieved after 1 h reaction. Homology modeling and substrate docking revealed that a typical catalytic triad is in contact with local water molecules to form a catalytic system. The results indicated this ADH could contribute to the further enzymatic synthesis of (S)-CHBE.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jun</publication><modification>2024-02-15T09:42:22.395Z</modification><creation>2020-06-04T07:10:35Z</creation></dates><accession>S-EPMC6458232</accession><cross_references><pubmed>31031438</pubmed><doi>10.1007/s12088-019-00795-0</doi></cross_references></HashMap>